WELCOMETOBENGALURU.IN · BENGALURU · ELECTRONIC CITY · WHITEFIELD · OUTER RING ROAD · KORAMANGALA · CHICKPET · SILK · AEROSPACE · START-UPS · GARDEN CITYIST
Home › Doing business › Biotech & Healthcare › Biocon and the Making of a Biotech City
Guide

Biocon and the Making of a Biotech City

How an enzyme business in a garage became the largest biotech company in India.

Kiran Mazumdar trained as a brewer in Australia and came home to Bengaluru in the 1970s to find that no Indian brewery would hire a woman as brewmaster. An Irish maker of enzymes was looking for an Indian partner; in 1978 she started Biocon India with it, in the garage of a rented house in Koramangala, with ten thousand rupees. The first products were enzymes taken from papaya and from the swim bladder of a tropical catfish, sold to brewers abroad.

Banks would not lend to a young woman in an unknown industry, and staff were hard to find. But the business of making enzymes by fermentation taught the company a skill few in India had. In the 1990s it turned that skill to medicines: first the ingredients of the cholesterol drugs called statins, then, in 2004, human insulin made in yeast, which brought the price of insulin in India down sharply.

Biocon listed its shares in 2004 and was valued at over a billion dollars on the first day. It went on to develop biosimilars — copies of the antibody medicines for cancer and arthritis — and to sell them in Europe and America. Syngene, the research company it had started in 1993, was listed separately in 2015.

Its larger effect was on the city. Scientists who had worked at Biocon and Syngene started Anthem Biosciences and many smaller firms; the state framed a biotechnology policy round the industry; and Bengaluru, already the software capital, became the biotech capital too.

Other guides

Back to

Check the current position

Companies move, change hands and change plans. These open a Google search in a new tab.

Company names and trademarks belong to their owners. WelcomeToBengaluru.in is an independent guide, is not connected to any company named, and does not rank or endorse. Confirm details independently. Disclaimer